http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 21 Aug 2026 06:30:37 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+PT+Change/MDxHealth+SA+%28MDXH%29+PT+Lowered+to+%242+at+BTIG/26958303.html (Updated - August 21, 2026 6:30 AM EDT) <p>BTIG analyst Mark Massaro lowered the price target on MDxHealth SA (NASDAQ: MDXH) to $2.00 (from $4.00) while maintaining a Buy rating.</p><p>The analyst commented: "In this note, we update our MDXH model following Q2 results and we introduce our quarterly estimates for 2028. We thought the key update from the Q2 call was that MDXH executed an assignment for the benefit of creditors (ABC) that assigned all of its assets and liabilities related to its recently wound-down Resolve business. Importantly, the $10.4M recoupment claim that Medicare contractor Novitas was pursuing from MDx related http://www.streetinsider.com/Analyst+PT+Change/MDxHealth+SA+%28MDXH%29+PT+Lowered+to+%242+at+BTIG/26958303.html Fri, 21 Aug 2026 06:30:37 -0400 MDXH http://www.streetinsider.com/Analyst+Comments/MDxHealth+SA+%28MDXH%29+PT+Lowered+to+%242+at+BTIG/26958303.html (Updated - August 21, 2026 6:30 AM EDT) <p>BTIG analyst Mark Massaro lowered the price target on MDxHealth SA (NASDAQ: MDXH) to $2.00 (from $4.00) while maintaining a Buy rating.</p><p>The analyst commented: "In this note, we update our MDXH model following Q2 results and we introduce our quarterly estimates for 2028. We thought the key update from the Q2 call was that MDXH executed an assignment for the benefit of creditors (ABC) that assigned all of its assets and liabilities related to its recently wound-down Resolve business. Importantly, the $10.4M recoupment claim that Medicare contractor Novitas was pursuing from MDx related http://www.streetinsider.com/Analyst+Comments/MDxHealth+SA+%28MDXH%29+PT+Lowered+to+%242+at+BTIG/26958303.html Fri, 21 Aug 2026 06:30:37 -0400 MDXH http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++MDxHealth+SA+++++++++++++++++++++++++++Filed+by%3A+LYTTON+LAURENCE+W/26937996.html si-local-file:///var/storage/secattach/20260817/26937996.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++MDxHealth+SA+++++++++++++++++++++++++++Filed+by%3A+LYTTON+LAURENCE+W/26937996.html Mon, 17 Aug 2026 16:07:00 -0400 MDXH O.00953707 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++MDxHealth+SA+++++++++++++++++++++++++++Filed+by%3A+LYTTON+LAURENCE+W/26937996.html si-local-file:///var/storage/secattach/20260817/26937996.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++MDxHealth+SA+++++++++++++++++++++++++++Filed+by%3A+LYTTON+LAURENCE+W/26937996.html Mon, 17 Aug 2026 16:07:00 -0400 MDXH O.00953707 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MDxHealth+SA++++++++++++++For%3A+Aug+13++Filed+by%3A+Bednarski+Eric/26937933.html si-local-file:///var/storage/secattach/20260817/26937933.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MDxHealth+SA++++++++++++++For%3A+Aug+13++Filed+by%3A+Bednarski+Eric/26937933.html Mon, 17 Aug 2026 16:05:00 -0400 MDXH O.00953707 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MDxHealth+SA++++++++++++++For%3A+Aug+13++Filed+by%3A+Bednarski+Eric/26937933.html si-local-file:///var/storage/secattach/20260817/26937933.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++MDxHealth+SA++++++++++++++For%3A+Aug+13++Filed+by%3A+Bednarski+Eric/26937933.html Mon, 17 Aug 2026 16:05:00 -0400 MDXH O.00953707 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++MDxHealth+SA+++++++++++++++++++++++++++Filed+by%3A+Bleichroeder+LP/26928882.html si-local-file:///var/storage/secattach/20260814/26928882.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++MDxHealth+SA+++++++++++++++++++++++++++Filed+by%3A+Bleichroeder+LP/26928882.html Fri, 14 Aug 2026 14:16:00 -0400 MDXH O.00953707 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++MDxHealth+SA+++++++++++++++++++++++++++Filed+by%3A+Bleichroeder+LP/26928882.html si-local-file:///var/storage/secattach/20260814/26928882.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13D++MDxHealth+SA+++++++++++++++++++++++++++Filed+by%3A+Bleichroeder+LP/26928882.html Fri, 14 Aug 2026 14:16:00 -0400 MDXH O.00953707 http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Press+Releases/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html <p>DENVER, Aug. 14, 2026 (GLOBE NEWSWIRE) -- (<a href="https://www.globenewswire.com/Tracker?data=1mc2KwGmoINcSaEjBrtPrbBQzd7jv8PGpqibTON5OEN6GCv0f9UXzmMtxN-lH9AFLSYTVXRagJ6_XCd2ZQXMTPvVMvmFGA1TCNY5DrB884w=" rel="nofollow" target="_blank"><u>247marketnews.com</u></a>) -- Today’s stock market coverage illustrates two very different kinds of momentum. <strong>NeOnc (NASDAQ: NTHI), MDxHealth (NASDAQ: MDXH), and Capricor Therapeutics (NASDAQ: CAPR) are fundamentally driven healthcare stories</strong>, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while <strong>Onfolio Holdings (NASDAQ:ONFO) is a structure-sensitive short squeeze</strong>.</p> <p><strong>NeOnc Technologies Holdings: Phase 2a Data Put NEO100 at the Center of the Story</strong></p> <p>NeOnc (NASDAQ: NTHI) is the clear fundamental headline among this group. http://www.streetinsider.com/Globe+Newswire/These+Biotech+Breakouts+and+Squeeze+Setups+Could+Be+Just+Getting+Started/26928253.html Fri, 14 Aug 2026 13:13:02 -0400 CAPR CAPR MDXH MDXH NTHI NTHI ONFO ONFO http://www.streetinsider.com/Analyst+PT+Change/MDxHealth+SA+%28MDXH%29+PT+Lowered+to+%243+at+Lake+Street/26925402.html Lake Street analyst Thomas Flaten lowered the price target on MDxHealth SA (NASDAQ: MDXH) to $3.00 (from $5.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/MDxHealth+SA+%28MDXH%29+PT+Lowered+to+%243+at+Lake+Street/26925402.html Fri, 14 Aug 2026 08:55:22 -0400 MDXH